WASHINGTON — The Food and Drug Administration on Thursday approved the oral contraceptive Opill for over-the-counter sales, making it the first hormonal contraceptive pill available in the U.S. without a prescription. The approval marks a major win for medical groups, including the American Medical Association and the American College of Obstetricians and Gynecologists, which have
WASHINGTON – The National Grocers Association (NGA), which represents independent supermarket operators, issued a statement on Wednesday contending that a proposed Food and Drug Administration rule on food traceability would disproportionately hurt small grocers. The trade group notes that the proposed rule aims to establish additional traceability recordkeeping requirements for persons who manufacture, process, pack
WASHINGTON — The Council for Responsible Nutrition (CRN) on Wednesday denounced the Food and Drug Administration’s rejection of two new dietary ingredient (NDI) notifications for full-spectrum hemp extract containing cannabidiol (CBD)—and urged Congress to act on pending legislative proposals that require the agency to address the lack of regulation of hemp-derived products. The following is
NEW YORK — Pharmacy chains CVS, Walgreens and Rite Aid and other retailers are pulling heartburn medication Zantac and its store-brand versions from their shelves after the Food and Drug Administration (FDA) warned it had detected low levels of a cancer-causing chemical in samples of the drug. The actions follow the FDA’s release of a
WASHINGTON — Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and Drug Administration next month. Health and Human Services Secretary Alex Azar said Tuesday that Sharpless will take the reins of the FDA after the resignation of Scott Gottlieb. The administration is seeking a permanent replacement
SILVER SPRING, Md. — Food and Drug Administration Commissioner Scott Gottlieb is resigning, effective in about a month. The 46-year-old Gottlieb, who has been commuting weekly to the FDA office here from his home in Connecticut, wants to spend more time with his family, an administration official told The Washington Post. Health and Human Services